DOI:

10.37988/1811-153X_2018_3_44

Experience in hyaluronic acid use in treatment of erosive and ulcerative lesions of the oral mucous membrane

Authors

  • S.Yu. Kosyuga 1, PhD in Medical Sciences, associate professor of the Pediatric dentistry Department
  • S.O. Voinova 1, postgraduate at the Pediatric dentistry Department
  • 1 Privolzhsky Research Medical University, 603005, Nizhniy Novgorod, Russia

Abstract

The article summarizes the data of domestic and foreign authors on the physical and chemical properties and the role of hyaluronic acid in the regulation of the healing process of the inflammatory lesion of the oral mucosa. The necessity and expediency of using hyaluronic acid in the complex treatment of erosive and ulcerative lesions of the oral mucosa is substantiated. The clinical case of the use of the hyaluronic acid-based gel “Hialudent” in the treatment of recurrent aphthous stomatitis is considered in detail.

Key words:

hyaluronic acid, recurrent aphthous stomatitis, “Hialudent”, connective tissue, inflammation

For Citation

[1]
Kosyuga S.Yu., Voinova S.O. Experience in hyaluronic acid use in treatment of erosive and ulcerative lesions of the oral mucous membrane. Clinical Dentistry (Russia).  2018; 3 (87): 44—46. DOI: 10.37988/1811-153X_2018_3_44

References

  1. Новикова М.А. Взаимосвязь свободнорадикального окисления липидов и антиоксидантной системы при заболеваниях пародонта. - Вестник стоматологии. - 2011; 3: 29-32.
  2. Понеделькина И.Ю., Лукина Е.С., Финоков В.Н. Кислые гликозаминогликаны и их химическая модификация. - Биоорганическая химия. - 2008; 34 (1): 5-28.
  3. Хабаров В.Н., Бойков П.Я., Чижова Н.А., Селянин М.А., Михайлова Н.П. Значение параметра молекулярной массы гиалуроновой кислоты в препаратах для эстетической медицины. - Вестник эстетической медицины. - 2009; 4 (8): 16-21.
  4. Хабриев Р.У., Камаев Н.О., Данилова Т.И., Кахоян Е.Г. Особенности действия гиалуронидаз различного происхождения на соединительную ткань. - Биомедицинская химия. - 2016; 1 (62): 82-8.
  5. Campo G.M., Avenoso A., Campo S., D’Ascola A., Nastasi G., Calatroni A. High molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. - Biochimie. - 2010; 92 (2): 204-15.
  6. Casale M., Moffa A., Vella P., Sabatino L., Capuano F., Salvinelli B. Hyaluronic acid: Perspectives in dentistry. A systematic review. - Int J Immunopathol Pharmacol. - 2016; 29 (4): 572-82.
  7. Cooper C.A., Brown K.K., Meletis C.D., Zabriskie N. Inflammation and Hyaluronic acid. - Alternat Complement Ther. - 2008; 14 (2): 78-84.
  8. Dahiya P., Kamal R. Hyaluronic acid: a boon in periodontal therapy. - N Am J Med Sci. - 2013; 5 (5): 309-15.
  9. Foschi D., Castoldi L., Radaelli E., Abelli P., Calderini G., Rastrelli A. et al. Hyaluronic acid prevents oxygen free-radical damage to granulation tissue: a study in rats. - Int J Tissue React. - 1990; 12 (6): 333-9.
  10. Fujioka-Kobayashi M., Müller H.D., Mueller A., Lussi A., Sculean A., Schmidlin P.R. et al. In vitro effects of hyaluronic acid on human periodontal ligament cells. - BMC Oral Health. - 2017; 17 (1): 44.
  11. Manzanares D., Monzon M.E., Savani R.C., Salathe M. Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON. - Am J Respir Cell Mol Biol. - 2007; 37(2): 160-8.
  12. Meyer K., Thompson R., Palmer J.W., Khorazo D. The nature of lysozyme action. - Science. - 1934; 79 (2038): 61.
  13. Scott J.E. Secondary structures in hyaluronan solutions: chemical and biological implications. - Ciba Found Symp. - 1989; 143: 6-15.
  14. Shuster S., Frost G.I., Csoka A.B., Formby B., Stern R. Hyaluronidase reduces human breast cancer xenografts in SCID mice. - Int J Cancer. - 2002; 102 (2): 192-7.
  15. Weindl G. Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. - Skin Pharmacology and physiology. - 2004; 17 (5): 207-13.
  16. Yasuda T. Hyaluronan inhibits cytokine production by lipopolysaccharide-stimulated U937 macrophages through down-regulation of NF-kappaB via ICAM-1. - Inflamm Res. - 2007; 56 (6): 246-53.
  17. Yasuda T. Hyaluronan inhibits prostaglandin E2 production via CD44 in U937 human macrophages. - Tohoku J Exper Med. - 2010; 220 (3): 229-35.

Published on

September 1, 2018